Prove Adoption, Track Momentum, & Scale Confidently in Emerging Procedural Markets.

Qsight Market Models provide a clear, market-level view of procedural utilization and device adoption across U.S. hospitals and ASCs. Built on real-world purchasing data, they help interventional and precision-focused MedTech companies validate growth, prioritize expansion, and plan for scale.

Request a Market Share Brief

Market Reality

Growth in Specialized MedTech Markets Is Hard to Prove, Until It Isn’t

For emerging and category-focused MedTech manufacturers, early momentum often appears uneven. Adoption may be strong in select centers or regions, while broader market penetration remains unclear, leaving teams to interpret growth signals from a limited internal footprint.

Without an external view of utilization across hospitals and ASCs, it’s difficult to determine whether adoption is accelerating, stalling, or shifting geographically. Qsight Market Models ground strategy in observed market behavior, helping specialized innovators validate momentum, prioritize expansion, and plan for scale with confidence.

Comprehensive Procedural Data

Gain near-real-time visibility into procedural utilization across 3,500+ U.S. hospitals and ASCs within neuro, vascular, and image-guided procedural categories.

Competitive & Category Benchmarking

Evaluate device adoption and performance within the context of total category growth and competitive activity.

Adoption & Growth Modeling

Track early adoption curves and model growth trajectories using observed facility-level utilization patterns.

Flexible Market Views

Analyze performance by procedure type, region, or site of care to focus expansion and commercialization efforts.

Explore U.S. Device Utilization Data

Request a market share brief to understand whether early interest is turning into broader procedural uptake.

Where Market-Level Visibility Accelerates Growth Decisions

Product Strategy

Validate whether adoption is expanding beyond early centers and identify where procedural momentum is strengthening or plateauing.

Commercial Planning

Prioritize geographies, sites of care, and procedures where demand is emerging to guide targeted sales and coverage strategies.

Investor Relations

Support growth narratives and funding discussions with external, market-level evidence of utilization and adoption trends.

Forecasting

Model realistic growth scenarios using observed adoption patterns to guide hiring, manufacturing, and commercialization timelines.

Market Model Data Coverage & Specifications

Markets Covered

The data includes neuro, vascular, interventional, and other procedure-driven MedTech segments across hospitals and ASCs.

Metrics Available

Market Models provide insight into procedural volume, utilization, adoption trends, market share, and growth rates.

Data Refresh Cadence

The data is updated monthly and quarterly to reflect recent shifts in utilization and emerging adoption patterns.

Coverage

The dataset captures purchasing activity from more than 3,500 U.S. hospitals and ambulatory surgery centers.

Why Specialized MedTech Innovators Trust the Data

Proven Adoption Across the Industry

Leading MedTech manufacturers rely on Qsight tools to understand how devices and procedures are performing on the market, from early traction to sustained adoption.

Built on Verified Real-World Data

Models are powered by Guidepoint’s proprietary real-world purchasing data and supported by validated quality assurance processes.

Designed to Fit Existing Planning Workflows

Market Models integrate easily with the forecasting, commercialization, and planning tools already employed by growth-oriented teams.

Ready to Validate Adoption and Plan for Scaled Growth?

Request a Market Share Brief

Request a focused briefing on U.S. procedural utilization, market share dynamics, and growth trends relevant to your portfolio and priority markets.